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Background: Streptococcus pneumoniae is associated with neurologic sequels, such as, seizures, sensory-motor
deficits, hearing loss, learning and memory impairment, which can occur in approximately 30 to 52% of surviving
patients. Neuronal damage can be caused by intense inflammatory reaction and direct effects of the bacteria
virulence factors. The aim of the present study was to evaluate the effects of the nonbacteriolytic antibiotic
daptomycin versus ceftriaxone on behavioral parameters in adult Wistar rats submitted to pneumococcal
meningitis.
Results: Ten days after induction we verified that the meningitis group with daptomycin treatment showed
retention of aversive memory; it presented memory of the object recognition at short term and long term. In
continuous multiple-trials step-down inhibitory avoidance task the meningitis group with ceftriaxone treatment
required approximately two times more stimulus to reach the acquisition criterion when compared with meningitis
group with daptomycin treatment. However, in the habituation memory test there were no differences in the
number of crossings and rearings in training and task sessions demonstrating habituation impairment to the
environment task in both meningitis groups.
Conclusions: The evidence of the present study shows the potential alternative of the treatment with daptomycin
in preventing learning and memory impairments caused by pneumococcal meningitis. Further investigations are
necessary to provide support for evaluation of daptomycin as an alternative treatment of bacterial meningitis.
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Pneumococcal meningitis is a life-threatening disease
associated with high mortality and morbidity rates.
Streptococcus pneumoniae meningitis mortality ranges
from 16 to 37% and it is associated with neurologic se-
quels, such as, seizures, sensory-motor deficits, hearing* Correspondence: tba@unesc.net
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reproduction in any medium, provided the orloss, learning and memory impairment, which can occur
in approximately 30 to 52% of surviving patients [1-5].
This microorganism can multiply within the cerebro-
spinal fluid (CSF) and it leads to the release of bacterial
components, which stimulates the production of cytokines
and other pro-inflammatory molecules in response to bac-
terial stimuli [6]. As consequence, polymorphonuclear are
attracted, activated and released in large amounts of super-
oxide anion and nitric oxide, leading to oxidative stress.
This cascade leads to mitochondrial damage and blood–
brain barrier breakdown. Both damages contribute to cell
injury during pneumococcal meningitis. The immune re-
sponse in cerebrospinal fluid has shown to play a key role
in this pathophysiology, principally to the development of
the brain damage [7]. Neuronal damage can be caused byral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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bacteria virulence factors [8]. The hippocampus is
surrounded by interstitial fluid which is contiguous with
the CSF, allowing bacterial toxins and pro-inflammatory
mediators to propagate into the parenchyma [9].
A nonbacteriolytic antibiotic but with high bactericidal
properties would minimize the cognitive damage. Since,
during the treatment with bacteriolytic antibiotics it
could contribute to increase the inflammation in the
subarachnoid space also through the release of bacterial
components [10]. Daptomicyn is an antibacterial agent
active against Gram-positive bacteria [11]. The bacteri-
cidal activity occurs by irreversible binding within the
bacterial cell membrane in a calcium-dependent process.
This leads to despolarization of the cell membrane and
inhibition of the RNA, DNA and protein synthesis,
which results in rapid bacterial cell death without trig-
gering immediate cell lysis [12]. Thus, in experimental
pneumococcal meningitis it has been demonstrated that
daptomicyn produces an enhanced bactericidal activity
[13]; it attenuates the CSF inflammation [14] and also
prevented cortical brain injury when compared to ceftri-
axone treatment [15].
In this context, the aim of the present study was to
evaluate the effects of the nonbacteriolytic antibiotic
daptomycin versus ceftriaxone on behavioral parameters in
adult Wistar rats submitted to pneumococcal meningitis.
Methods
Infecting organism
S. pneumoniae (serotype 3) was cultured overnight in
10 ml of Todd Hewitt broth, diluted in fresh medium and
grown to logarithmic phase. This culture was centrifuged
for 10 min at (5,000×g) and resuspended in sterile saline
to the concentration of 5×109 cfu/ml. The size of the
inoculum was confirmed by quantitative cultures [16,17].
Animal model of meningitis
Adult male Wistar rats (250–350 g body weight), from
our breeding colony were used for the experiments. All
procedures were approved by the Animal Care and Ex-
perimentation Committee of UNESC, Brazil, and followed
in accordance with the National Institute of Health Guide
for the Care and Use of Laboratory Animals (NIH Publi-
cations No. 80–23) revised in 1996. All surgical proce-
dures and bacterial inoculations were performed under
anesthesia, consisting of an intraperitoneal administration
of ketamine (6.6 mg/kg), xylazine (0.3 mg/kg), and
acepromazine (0.16 mg/kg) [18]. Rats underwent a cis-
terna magna tap with a 23-gauge needle. The animals re-
ceived either 10 μl of sterile saline as a placebo or an
equivalent volume of S. pneumoniae suspension. At the
time of inoculation, animals received fluid replacement
and were subsequently returned to their cages [19,20].Eighteen hours later, the meningitis was documented by a
quantitative culture of 5 μl of CSF obtained by puncture
of the cisterna magna [16]. The animals were randomly in
three different groups sham (control group), meningitis
with daptomicyn treatment and meningitis with ceftriax-
one treatment. The daptomycin (CubicinW; 50 mg/kg
body weight) and ceftriaxone (100 mg/kg body weight)
were administered subcutaneously [s.c.]) during 7 days.
After 10 days, the animals were free from infection.
We performed blood cultures that were all negative in
this period. Thus, the animals were separately under-
gone to four behavioral tasks: a) open field; b) object
recognition; c) step-down inhibitory avoidance task
(single-training) and d) continuous multiple-trials step-
down inhibitory avoidance task.
Behavioral tasks
The animals underwent separately to four behavioral
tasks: habituation to an open field, step-down inhibitory
avoidance task, continuous multiple-trials step-down in-
hibitory avoidance task and object recognition. All be-
havioral procedures were conducted between 13:00 and
16:00 p.m. in a sound-isolated room, and each animal
performed only one behavior test. All behavioral tests
were recorded by the same person who was blind to the
animal group.
Open field test
The behavior was assessed in the open field apparatus in
order to evaluate both locomotor and exploratory activ-
ities. The apparatus is a 40 cm × 60 cm open field
surrounded by 50 cm high walls made of brown plywood
with a frontal glasswall. The floor of the open field is di-
vided into 9 rectangles by black lines. The animals were
gently placed on the left rear quadrant and then left
alone to explore the arena for 5 min (training session).
Immediately after this procedure, the animals were taken
back to their home cage and 24 h later they were sub-
mitted again to a similar open-field session (test session).
Every cross of the black lines and rearing performed in
both sessions were counted for 5 min. The decrease in
the number of crossings and rearings between the two
sessions was taken as a measure of the retention of ha-
bituation memory [21].
Object recognition
This task evaluates the non-aversive and non-spatial
memory. The apparatus and procedures for the object
recognition task have been described elsewhere [22].
Briefly, the task took place in a 40 × 50 cm open field
surrounded by 50 cm high walls made of plywood with a
frontal glass wall. The floor of the open field was divided
into 12 equal rectangles by black lines. All animals were
submitted to a habituation session where they were
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objects were placed in the box during the habituation
trial. The total number of crossings of the black lines
and rearings performed in this session were evaluated as
locomotors and exploratory activity, respectively. The
training was conducted by placing individual rats for 5
min in the field, in which two identical objects (objects
A1 and A2, both being cubes) were positioned in two
adjacent corners, 10 cm from the walls. In a short-term
recognition memory test given 1.5 h after training, the
rats explored the open field for 5 min in the presence of
one familiar (A) and one novel (B, a pyramid with a
square-shaped base) object. All objects had similar textures
(smooth), colors (blue), and sizes (weight 150–200 g), but
distinctive shapes. A recognition index calculated for each
animal is reported as the ratio TB/(TA + TB) (TA = time
spent exploring the familiar object A; TB = time spent ex-
ploring the novel object B). In a long-term recognition
memory test given 24 h after training, the same rats were
allowed to explore the field for 5 min in the presence of the
familiar object A and a novel object C (a sphere with a
square shaped base). Recognition memory was evaluated
using the same method of the short-term memory test. Ex-
ploration was defined as sniffing (exploring the object 3–5
cm away from it) or touching the object with the nose and/
or forepaws.
Step-down inhibitory avoidance task
This task evaluates aversive memory. The apparatus and
procedures have been described in previous reports
[23,24]. Briefly, the training apparatus was a 50 × 25 ×
25 cm acrylic box (Albarsch, Porto Alegre, Brazil) which
the floor was consisted of parallel caliber stainless steel
bars (1 mm diameter) spaced 1 cm apart from each
other. A 7 cm-wide, 2.5 cm-high platform was placed on
the floor of the box against the left wall. In the training
trial, animals were placed on the platform and their la-
tency to step down on the grid with all four paws was
measured with an automatic device. Immediately after
stepping down on the grid, the animals received a
0.4 mA, 2.0 s foot shock and returned to their home cage.
A retention test trial was performed 24 h after training
(long-term memory). The retention test trial was pro-
cedurally identical to the training, except that no foot
shock was presented. The retention test step-down latency
(maximum, 180 s) was used as a measure of inhibitory
avoidance retention. Reactivity to the foot shock was
evaluated in the same apparatus used for inhibitory
avoidance, except that the platform was removed. Each
animal was placed on the grid and allowed 1 min for
habituation period prior to the start of a series of shocks
(0.5 s) delivered at 10 s intervals. The shock intensities
ranged from 0.1 to 0.5 mA in 0.1 mA increments. The
adjustments in the shock intensity were made inaccordance to each animal’s response. The intensity was
raised by 1 unit when no response occurred and lowered
by 1 unit when a response was made. A “flinch” response
was defined as the withdrawal of one paw from the grid
floor, and a “jump” response was defined as rapid
withdrawal of three or four paws. Two measurements
of the “flinch” threshold were made and then two
measurements of the “jump” threshold were made. For
each animal the mean of the two scores for the flinch and
the jump thresholds were calculated [25,26].
Continuous multiple-trials step-down inhibitory
avoidance task
This task evaluates aversive memory in the test section
and learning when analyzing the number of training tri-
als required for the acquisition criterion (see below). It
was performed in the same step-down inhibitory avoid-
ance apparatus; however, in the training session, the ani-
mal was placed on the platform and immediately after
stepping down on the grid, received a 0.3 mA, 2.0 s foot
shock. This procedure continued until the rat remained
on the platform for 50 s. The animal was then returned
to the home cage. The number of training trials required
to reach the acquisition criterion of 50 s on the platform
was recorded. The retention test was performed 24 h
later (long-term memory) [27].
Statistics
Data from the habituation to an open field task is
reported as mean ± SEM, and it was analyzed by the
paired Student’s t test and ANOVA post-hoc Tukey.
Data from the object recognition task and inhibitory
avoidance task are reported as median and interquartile
ranges, and comparisons among groups were performed
using Mann–Whitney U tests. The within-individual
groups were analyzed by Wilcoxon’s tests. Data from
continuous multiple-trials step-down inhibitory avoid-
ance task the trials were reported as mean ± SD, and
were analyzed by the ANOVA post-hoc Tukey. Data
from the latency time was reported as median and inter-
quartile ranges, and comparisons among groups were
performed using Mann–Whitney U tests. In all compari-
sons, p<0.05 indicated statistical significance.
Results
In the open-field task, Figure 1, there were no differences
in the number of crossings and rearings among groups in
the habituation to the open-field training session (p>0.05)
demonstrating no difference in motor and exploratory ac-
tivity among groups. In the sham group, there was statis-
tical difference between training and test session (crossing
t = 9.161, df = 9, p = 0.0001; rearings t = 10.672, df = 9,
p = 0.0001) demonstrating habituation memory.






























Figure 1 Open field test 10 days after induction of meningitis by S. pneumoniae. Data are reported as mean ± SEM. n=10 per group, and
were analyzed by the paired Student’s t test and ANOVA post-hoc Tukey. *p<0.05 vs. Training.
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df = 9, p = 0.086; rearings t = 0.949, df = 9, p = 0.369) and
the meningitis/daptomycin group (crossing t = 2.195,
df = 9, p = 0.056; rearings t = 0.884 df = 9, p = 0.400) there
were no differences between training session and test
session suggesting memory impairment in both groups.
The object recognition task in Figure 2, the animals of
meningitis/cefriaxone group presented impairment of novel
object recognition memory, i.e., they did not spend a sig-
nificantly greater time exploring the novel object, present-
ing memory impairment during short term (Z =−0.866,
p = 0.386) and long term memory (Z = −0.051, p = 0.959).
However, the animals of meningitis/daptomycin group



















Figure 2 Object recognition task 10 days after induction of meningiti
evaluated at 1.5 h after training (STM) and the long-term recognition mem
as median and interquartile ranges, and comparisons among groups were
individual groups were analyzed by Wilcoxon’s tests. *p<0.05 test vs. trainin(Z = −2.499, p = 0.012) and long term (Z = −2.395,
p = 0.017) retention test sessions in comparison to the
training trial.
Figure 3, the step-down latency. In the training session
there was not significant difference in the latency time
among the groups (p>0.05). In the meningitis/ceftriax-
one group there wasn’t difference in the latency time
between training and test (Z=−1.703; p=0.089) present-
ing memory impairment. In the meningitis/daptomycin
group there was difference between training and test
session (Z=−2.810; p=0.005) demonstrating aversive
memory in this group.
Figure 4, continuous multiple trials step-down inhibi-





s by S. pneumoniae. The short-term recognition memory the test is
ory the test is evaluated at 24 h after training (LTM). Data are reported
performed using Mann–Whitney U tests, n=10 per group. The within-
g.

















Figure 3 Latency to step-down in the inhibitory avoidance task 10 days after induction of meningitis by S. pneumoniae. Data are
reported as median and interquartile ranges, and comparisons among groups were performed using Mann–Whitney U tests, n=10 per group. The
within-individual groups were analyzed by Wilcoxon’s tests. *p<0.05 vs. training.
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p = 0.002) required to reach the acquisition criterion
(50 s on the platform) in the meningitis/ceftriaxone
group when compared to the sham group, Figure 4A.
The results of this task suggest that the meningitis/























Figure 4 Continuous multiple trials step-down inhibitory avoidance t
from the trials is reported as mean ± SD, and were analyzed by the ANOVA
from the latency time is reported as median and interquartile ranges, and
Figure 4 B. *p<0.05 vs. Sham.more stimulus to reach the acquisition criterion when
compared with the sham group and with meningitis/
daptomycin group. Meningitis/ceftriaxone group had
learning and impairment memory. In the retention
test, there was no difference among groups for all the
times tested, Figure 4B.is + Cefriaxone Meningitis + Daptomycin
*
+ Cefriaxone Meningitis + Daptomycin
ask 10 days after induction of meningitis by S. pneumoniae. Data
post-hoc Tukey, n=10 per group, Figure 4 A. *p<0.05 vs. Sham. Data
comparisons among groups were performed by Wilcoxon’s tests,
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In spite of significant advances in pneumococcal menin-
gitis treatment, it remains one of the most important
worldwide infectious diseases and it is still correlated
with elevated mortality and morbidity. Moreover, a large
number of survivors present permanent neurological se-
quelae [5,6].
The present study suggests a beneficial effect of ther-
apy with daptomycin on memory and learning impair-
ments in an animal model of pneumococcal meningitis.
In the habituation memory test there was no difference
between treatments with daptomycin and ceftriaxone,
both groups demonstrated impairments in this memory.
However, the meningitis group with daptomycin treat-
ment showed retention of aversive memory and the ani-
mals also presented memory of the object recognition at
short term and long term. In continuous multiple-trials
step-down inhibitory avoidance task, the meningitis
group with ceftriaxone treatment required approxi-
mately two times more stimulus to reach the acquisition
criterion when compared with meningitis group with
daptomycin treatment.
Several studies with daptomycin treatment on experi-
mental pneumococcal meningitis with favorable results
have been reported. Daptomycin cleared the bacteria
more efficiently from the CSF than ceftriaxone; de-
creased the inflammatory host response, as assessed by
the matrix metalloproteinase-9, IL-1β, IL-10, IL-18,
monocyte chemoattractant protein 1 (MCP-1), macro-
phage inflammatory protein 1 alpha (MIP-1alpha) in
CSF and prevented the development of cortical injury
[16,28]. During bacterial multiplication into the CSF, it
released products that are highly immunogenic and can
lead to an increased immune response of the host
[10,16]. Whereas, in experimental pneumococcal menin-
gitis model the animals presented, in the first twenty
four hours, elevated levels of TNF-α and CINC-1 in
the hippocampus and TNF-α, IL-1β, IL-6 and CINC-1
in frontal cortex [29]. Furthermore, the host inflamma-
tory response can be exacerbated by the effects of
bacteriolytic antibiotics [30]. The release of teichoic
acids (TAs) and lipoteichoic acids (LTAs) from
S. pneumoniae showed intense during exposure to
ceftriaxone and meropenen [31]. Daptomycin is an anti-
bacterial agent and nonbacteriolytic active against
the main Gram-positive pathogens [11,32], including
penicillin and cephalosporin resistant pneumococci [33].
Daptomycin was highly efficacious against penicillin-
resistant and quinolone-resistant pneumococci [34], in
addition, ceftriaxona with adjunctive daptomycin treat-
ment attenuates brain damage and hearing loss more
efficiently than rifampin in infant rats induced by
pneumococcal meningitis [35]. When the microorgan-
ism is killed without lyses, it provides the advantage ofreducing the release of bacterial molecules, such as,
TAs, LTAs, peptidoglycan and bacterial DNA [36]. These
effects could be an explanation for the observation that
daptomycin prevented the development of cortical brain
injury in experimental pneumococcal meningitis [16]
and prevented memory impairment in our study. Previ-
ous studies demonstrated that 10 days after pneumococ-
cal meningitis induction animals treated with ceftriaxone
presented memory and learning deficits, anxiety-like and
depressive-like behavior [37].
Conclusions
The evidence of the present study suggests the potential
alternative of the treatment with daptomycin in
preventing learning and memory impairments caused by
pneumococcal meningitis. Further investigations are ne-
cessary to provide support for evaluation of daptomycin
as an alternative treatment for bacterial meningitis.
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